Crystal Structures of the TRAF2: CIAP2 and the TRAF1: TRAF2: CIAP2 Complexes: Affinity, Specificity, and Regulation

Overview

Journal Mol Cell

Publisher Cell Press

Specialty Cell Biology

Date 2010 Apr 14

PMID 20385093

Citations 103

Authors

Chao Zheng

Venkataraman Kabaleeswaran

Yaya Wang

Genhong Cheng

Hao Wu

Affiliations

Soon will be listed here.

Abstract

TRAF1/2 and cIAP1/2 are members of the TNF receptor-associated factor (TRAF) and the inhibitor of apoptosis (IAP) families, respectively. They are critical for canonical and noncanonical NF-kappaB signaling pathways. Here, we report the crystal structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 complexes. A TRAF2 trimer interacts with one cIAP2 both in the crystal and in solution. Two chains of the TRAF2 trimer directly contact cIAP2, and key residues at the interface are confirmed by mutagenesis. TRAF1 and TRAF2 preferentially form the TRAF1: (TRAF2)(2) heterotrimer, which interacts with cIAP2 more strongly than TRAF2 alone. In contrast, TRAF1 alone interacts very weakly with cIAP2. Surprisingly, TRAF1 and one chain of TRAF2 in the TRAF1: (TRAF2)(2): cIAP2 ternary complex mediate interaction with cIAP2. Because TRAF1 is upregulated by many stimuli, it may modulate the interaction of TRAF2 with cIAP1/2, which explains regulatory roles of TRAF1 in TNF signaling.

Citing Articles

TRAF1 promotes osteoclastogenesis by enhancing metabolic adaptation to oxidative phosphorylation in an AKT-dependent manner.

Kang H, Peng R, Dong Y, Dong Y, Liao F, Zhu M Mol Ther. 2025; 33(3):933-949.

PMID: 39863932 PMC: 11897774. DOI: 10.1016/j.ymthe.2025.01.040.

Exploring TNFR1: from discovery to targeted therapy development.

Li Y, Ye R, Dai H, Lin J, Cheng Y, Zhou Y J Transl Med. 2025; 23(1):71.

PMID: 39815286 PMC: 11734553. DOI: 10.1186/s12967-025-06122-0.

CD137-expressing regulatory T cells in cancer and autoimmune diseases.

Lee K, Mei Y, Liu H, Schwarz H Mol Ther. 2024; 33(1):51-70.

PMID: 39668561 PMC: 11764688. DOI: 10.1016/j.ymthe.2024.12.010.

TRAF1 from a Structural Perspective.

Jang H, Kim S, Kim D, Han J, Park H Biomolecules. 2024; 14(5).

PMID: 38785916 PMC: 11117997. DOI: 10.3390/biom14050510.

Differential protein-protein interactions underlie signaling mediated by the TCR and a 4-1BB domain-containing CAR.

Ritmeester-Loy S, Draper I, Bueter E, Lautz J, Zhang-Wong Y, Gustafson J Sci Signal. 2024; 17(826):eadd4671.

PMID: 38442200 PMC: 10986860. DOI: 10.1126/scisignal.add4671.

References

Yin Q, Lin S, Lamothe B, Lu M, Lo Y, Hura G . E2 interaction and dimerization in the crystal structure of TRAF6. Nat Struct Mol Biol. 2009; 16(6):658-66. PMC: 2834951. DOI: 10.1038/nsmb.1605. View

Hsu H, Shu H, Pan M, Goeddel D . TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 1996; 84(2):299-308. DOI: 10.1016/s0092-8674(00)80984-8. View

Varfolomeev E, Blankenship J, Wayson S, Fedorova A, Kayagaki N, Garg P . IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell. 2007; 131(4):669-81. DOI: 10.1016/j.cell.2007.10.030. View

Carpentier I, Beyaert R . TRAF1 is a TNF inducible regulator of NF-kappaB activation. FEBS Lett. 1999; 460(2):246-50. DOI: 10.1016/s0014-5793(99)01356-3. View

Varfolomeev E, Wayson S, Dixit V, Fairbrother W, Vucic D . The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2. J Biol Chem. 2006; 281(39):29022-9. DOI: 10.1074/jbc.M605116200. View

Ea C, Deng L, Xia Z, Pineda G, Chen Z . Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell. 2006; 22(2):245-57. DOI: 10.1016/j.molcel.2006.03.026. View

Wang L, Du F, Wang X . TNF-alpha induces two distinct caspase-8 activation pathways. Cell. 2008; 133(4):693-703. DOI: 10.1016/j.cell.2008.03.036. View

Vince J, Pantaki D, Feltham R, Mace P, Cordier S, Schmukle A . TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-{kappa}b and to prevent tnf-induced apoptosis. J Biol Chem. 2009; 284(51):35906-15. PMC: 2791019. DOI: 10.1074/jbc.M109.072256. View

LaCasse E, Mahoney D, Cheung H, Plenchette S, Baird S, Korneluk R . IAP-targeted therapies for cancer. Oncogene. 2008; 27(48):6252-75. DOI: 10.1038/onc.2008.302. View

10.

Bertrand M, Milutinovic S, Dickson K, Ho W, Boudreault A, Durkin J . cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell. 2008; 30(6):689-700. DOI: 10.1016/j.molcel.2008.05.014. View

11.

Rothe M, Pan M, Henzel W, Ayres T, Goeddel D . The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell. 1995; 83(7):1243-52. DOI: 10.1016/0092-8674(95)90149-3. View

12.

Lu M, Lin S, Huang Y, Kang Y, Rich R, Lo Y . XIAP induces NF-kappaB activation via the BIR1/TAB1 interaction and BIR1 dimerization. Mol Cell. 2007; 26(5):689-702. PMC: 1991276. DOI: 10.1016/j.molcel.2007.05.006. View

13.

Wicovsky A, Henkler F, Salzmann S, Scheurich P, Kneitz C, Wajant H . Tumor necrosis factor receptor-associated factor-1 enhances proinflammatory TNF receptor-2 signaling and modifies TNFR1-TNFR2 cooperation. Oncogene. 2009; 28(15):1769-81. DOI: 10.1038/onc.2009.29. View

14.

Yin Q, Lamothe B, Darnay B, Wu H . Structural basis for the lack of E2 interaction in the RING domain of TRAF2. Biochemistry. 2009; 48(44):10558-67. PMC: 2830148. DOI: 10.1021/bi901462e. View

15.

Thome M . CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nat Rev Immunol. 2004; 4(5):348-59. DOI: 10.1038/nri1352. View

16.

Zarnegar B, Wang Y, Mahoney D, Dempsey P, Cheung H, He J . Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat Immunol. 2008; 9(12):1371-8. PMC: 2676931. DOI: 10.1038/ni.1676. View

17.

Mahoney D, Cheung H, Mrad R, Plenchette S, Simard C, Enwere E . Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc Natl Acad Sci U S A. 2008; 105(33):11778-83. PMC: 2575330. DOI: 10.1073/pnas.0711122105. View

18.

Lee J, Hong U, Lee T, Yoon S, Yoon J . Mass spectrometric analysis of tumor necrosis factor receptor-associated factor 1 ubiquitination mediated by cellular inhibitor of apoptosis 2. Proteomics. 2004; 4(11):3376-82. DOI: 10.1002/pmic.200401000. View

19.

Samuel T, Welsh K, Lober T, Togo S, Zapata J, Reed J . Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases. J Biol Chem. 2005; 281(2):1080-90. DOI: 10.1074/jbc.M509381200. View

20.

Wu C, Conze D, Li T, Srinivasula S, Ashwell J . Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. Nat Cell Biol. 2006; 8(4):398-406. DOI: 10.1038/ncb1384. View